Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence

Home / Intelligence / Analyst Reports / Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence

Trinity Life Sciences is a Leader in Everest Group’s 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment—with its distinction rooted in exceptional, tangible outcomes delivered for clients across the life sciences sector.

More about the report

Everest Group’s PEAK Matrix® is a framework to assess the overall vision, capability and market impact of platform providers.

The assessment is based on Everest Group’s PEAK Matrix® Request For Information process for the calendar year 2024, interactions with leading life sciences commercial providers, client reference checks, and an ongoing analysis of the life sciences digital services market. 

Featured case studies

Real results delivered for Trinity clients:
Accelerated brand growth & return on investment (ROI)

10X ROI for small biopharma: Trinity helped a small biopharma manufacturer craft and execute a data-driven 100-day brand acceleration plan. By uniting market analytics, prescriber behavior studies and a holistic commercial strategy—including sales force sizing and data infrastructure—Trinity enabled the client to realize a tenfold return on their investment.

Strategic guidance for growth & market expansion

Informed commercial resource allocation: For a clinical-stage biopharma company, Trinity provided forecasts and direction on expanding beyond the initial approved indication. A second patient population was selected based on Trinity’s research. Trinity’s forecasts were also a key input for decisions regarding sales force and marketing budgets.

Enhanced field force productivity with AI

20-30% lift in field rep productivity: Trinity’s AI-driven call planning engine, implemented at a midsize pharma company, identified high-potential healthcare providers (HCPs) with greater accuracy and prioritized engagement efforts to maximize opportunities. The result? Reps saw a 20-30% productivity increase, non-target calls dropped by ~20% and new-to-brand prescriptions increased in high and medium market segments—a success recognized by the client’s CEO in external communications.

Transforming medical science liaison (MSL) engagement

Streamlined, AI-powered field operations: Working with a top-three global pharma company, Trinity’s MSL Advisor suite replaced an existing internal solution, streamlining MSL preparation and reducing administrative burden. Trinity MSL Advisor was initially deployed to one brand and expanded to all brands, supporting multiple commercial roles.

Faster, smarter knowledge access for decision-making

GenAI-driven information retrieval: A rare-disease biotech client struggling to tap the value of vast brand research and medical content adopted Trinity’s Brand Insights AI. By making their data archives searchable, the accessibility and usability of strategic insights was enhanced. Trinity’s Brand Insights AI enabled faster decision-making and reduced research redundancy.

Access the report:

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

The growing emphasis on patient- and HCP-centricity to deliver superior customer experiences has modernized commercialization strategies, placing data, analytics, and AI at the core of life sciences enterprises’ go-to-market efforts. As a result, they are turning to strategic partners with domain-led digital expertise and scalable technology solutions to navigate the evolving landscape. Trinity Life Sciences’ generative and agentic AI investments, the TrinityEDGE suite of commercial solutions, its targeted domain-centric partnerships, and its thought leadership are augmented by its client flexibility and responsiveness. This focus has led to its recognition as a Leader in Everest Group’s Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.

—Durga Ambati, Practice Director at Everest Group

Disclaimer
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis.  All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking.  To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports. 

Related Intelligence